0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anthrax Vaccines Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Auto-8216
Home | Market Reports | Health | Pharmacy
Global Anthrax Vaccines Market Insights and Forecast to 2028

Global Anthrax Vaccines Market Insights and Forecast to 2028

Code: QYRE-Auto-8216
Report
January 2022
128 Pages
QYResearch
Region: Global, Europe, South America, China,
Description
Table of Content
Tables & Figures
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Market Analysis and Insights: Global Anthrax Vaccines Market

Due to the COVID-19 pandemic, the global Anthrax Vaccines market size is estimated to be worth US$ 709 million in 2022 and is forecast to a readjusted size of US$ 1100.3 million by 2028 with a CAGR of 7.6% during the review period.

Fully considering the economic change by this health crisis, Live Vaccines accounting for % of the Anthrax Vaccines global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Human Use segment is altered to an % CAGR throughout this forecast period.
Global Anthrax Vaccines key players include Emergent BioSolutions, Merial, Merck, Zoetis, PharmAthene, etc. Global top five players hold a share about 70%.
North America is the largest market, with a share about 60%, followed by Latin America and Europe, having a total share about 20 percent.
In terms of product, Live Vaccines is the largest segment, with a share about 95%. And in terms of application, the largest application is Human Use, followed by Animal Use.
Global Anthrax Vaccines Scope and Segment
Anthrax Vaccines market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Anthrax Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Live Vaccines
Cell free PA Vaccines

Segment by Application

Human Use
Animal Use

BY COMPANY

Emergent BioSolutions
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC

BY REGION

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
1 Study Coverage
1.1 Anthrax Vaccines Product Introduction
1.2 Market by Type
1.2.1 Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Live Vaccines
1.2.3 Cell free PA Vaccines
1.3 Market by Application
1.3.1 Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Human Use
1.3.3 Animal Use
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Anthrax Vaccines Sales Estimates and Forecasts 2017-2028
2.2 Global Anthrax Vaccines Revenue Estimates and Forecasts 2017-2028
2.3 Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Anthrax Vaccines Sales by Region
2.4.1 Global Anthrax Vaccines Sales by Region (2017-2022)
2.4.2 Global Sales Anthrax Vaccines by Region (2023-2028)
2.5 Global Anthrax Vaccines Revenue by Region
2.5.1 Global Anthrax Vaccines Revenue by Region (2017-2022)
2.5.2 Global Anthrax Vaccines Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Anthrax Vaccines Sales by Manufacturers
3.1.1 Global Top Anthrax Vaccines Manufacturers by Sales (2017-2022)
3.1.2 Global Anthrax Vaccines Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anthrax Vaccines in 2021
3.2 Global Anthrax Vaccines Revenue by Manufacturers
3.2.1 Global Anthrax Vaccines Revenue by Manufacturers (2017-2022)
3.2.2 Global Anthrax Vaccines Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Anthrax Vaccines Revenue in 2021
3.3 Global Anthrax Vaccines Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Anthrax Vaccines Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anthrax Vaccines Sales by Type
4.1.1 Global Anthrax Vaccines Historical Sales by Type (2017-2022)
4.1.2 Global Anthrax Vaccines Forecasted Sales by Type (2023-2028)
4.1.3 Global Anthrax Vaccines Sales Market Share by Type (2017-2028)
4.2 Global Anthrax Vaccines Revenue by Type
4.2.1 Global Anthrax Vaccines Historical Revenue by Type (2017-2022)
4.2.2 Global Anthrax Vaccines Forecasted Revenue by Type (2023-2028)
4.2.3 Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)
4.3 Global Anthrax Vaccines Price by Type
4.3.1 Global Anthrax Vaccines Price by Type (2017-2022)
4.3.2 Global Anthrax Vaccines Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Anthrax Vaccines Sales by Application
5.1.1 Global Anthrax Vaccines Historical Sales by Application (2017-2022)
5.1.2 Global Anthrax Vaccines Forecasted Sales by Application (2023-2028)
5.1.3 Global Anthrax Vaccines Sales Market Share by Application (2017-2028)
5.2 Global Anthrax Vaccines Revenue by Application
5.2.1 Global Anthrax Vaccines Historical Revenue by Application (2017-2022)
5.2.2 Global Anthrax Vaccines Forecasted Revenue by Application (2023-2028)
5.2.3 Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)
5.3 Global Anthrax Vaccines Price by Application
5.3.1 Global Anthrax Vaccines Price by Application (2017-2022)
5.3.2 Global Anthrax Vaccines Price Forecast by Application (2023-2028)
6 North America
6.1 North America Anthrax Vaccines Market Size by Type
6.1.1 North America Anthrax Vaccines Sales by Type (2017-2028)
6.1.2 North America Anthrax Vaccines Revenue by Type (2017-2028)
6.2 North America Anthrax Vaccines Market Size by Application
6.2.1 North America Anthrax Vaccines Sales by Application (2017-2028)
6.2.2 North America Anthrax Vaccines Revenue by Application (2017-2028)
6.3 North America Anthrax Vaccines Market Size by Country
6.3.1 North America Anthrax Vaccines Sales by Country (2017-2028)
6.3.2 North America Anthrax Vaccines Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Anthrax Vaccines Market Size by Type
7.1.1 Europe Anthrax Vaccines Sales by Type (2017-2028)
7.1.2 Europe Anthrax Vaccines Revenue by Type (2017-2028)
7.2 Europe Anthrax Vaccines Market Size by Application
7.2.1 Europe Anthrax Vaccines Sales by Application (2017-2028)
7.2.2 Europe Anthrax Vaccines Revenue by Application (2017-2028)
7.3 Europe Anthrax Vaccines Market Size by Country
7.3.1 Europe Anthrax Vaccines Sales by Country (2017-2028)
7.3.2 Europe Anthrax Vaccines Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Anthrax Vaccines Market Size by Type
8.1.1 Asia Pacific Anthrax Vaccines Sales by Type (2017-2028)
8.1.2 Asia Pacific Anthrax Vaccines Revenue by Type (2017-2028)
8.2 Asia Pacific Anthrax Vaccines Market Size by Application
8.2.1 Asia Pacific Anthrax Vaccines Sales by Application (2017-2028)
8.2.2 Asia Pacific Anthrax Vaccines Revenue by Application (2017-2028)
8.3 Asia Pacific Anthrax Vaccines Market Size by Region
8.3.1 Asia Pacific Anthrax Vaccines Sales by Region (2017-2028)
8.3.2 Asia Pacific Anthrax Vaccines Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Anthrax Vaccines Market Size by Type
9.1.1 Latin America Anthrax Vaccines Sales by Type (2017-2028)
9.1.2 Latin America Anthrax Vaccines Revenue by Type (2017-2028)
9.2 Latin America Anthrax Vaccines Market Size by Application
9.2.1 Latin America Anthrax Vaccines Sales by Application (2017-2028)
9.2.2 Latin America Anthrax Vaccines Revenue by Application (2017-2028)
9.3 Latin America Anthrax Vaccines Market Size by Country
9.3.1 Latin America Anthrax Vaccines Sales by Country (2017-2028)
9.3.2 Latin America Anthrax Vaccines Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Anthrax Vaccines Market Size by Type
10.1.1 Middle East and Africa Anthrax Vaccines Sales by Type (2017-2028)
10.1.2 Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2028)
10.2 Middle East and Africa Anthrax Vaccines Market Size by Application
10.2.1 Middle East and Africa Anthrax Vaccines Sales by Application (2017-2028)
10.2.2 Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2028)
10.3 Middle East and Africa Anthrax Vaccines Market Size by Country
10.3.1 Middle East and Africa Anthrax Vaccines Sales by Country (2017-2028)
10.3.2 Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Emergent BioSolutions
11.1.1 Emergent BioSolutions Corporation Information
11.1.2 Emergent BioSolutions Overview
11.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Emergent BioSolutions Recent Developments
11.2 Merial
11.2.1 Merial Corporation Information
11.2.2 Merial Overview
11.2.3 Merial Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merial Recent Developments
11.3 Merck
11.3.1 Merck Corporation Information
11.3.2 Merck Overview
11.3.3 Merck Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Merck Recent Developments
11.4 Zoetis
11.4.1 Zoetis Corporation Information
11.4.2 Zoetis Overview
11.4.3 Zoetis Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Zoetis Recent Developments
11.5 Bayer Sanidad Animal
11.5.1 Bayer Sanidad Animal Corporation Information
11.5.2 Bayer Sanidad Animal Overview
11.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Bayer Sanidad Animal Recent Developments
11.6 Colorado Serum
11.6.1 Colorado Serum Corporation Information
11.6.2 Colorado Serum Overview
11.6.3 Colorado Serum Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Colorado Serum Recent Developments
11.7 PharmAthene
11.7.1 PharmAthene Corporation Information
11.7.2 PharmAthene Overview
11.7.3 PharmAthene Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 PharmAthene Recent Developments
11.8 Tiankang
11.8.1 Tiankang Corporation Information
11.8.2 Tiankang Overview
11.8.3 Tiankang Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Tiankang Recent Developments
11.9 Biogénesis-Bago
11.9.1 Biogénesis-Bago Corporation Information
11.9.2 Biogénesis-Bago Overview
11.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Biogénesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Biogénesis-Bago Recent Developments
11.10 CAVAC
11.10.1 CAVAC Corporation Information
11.10.2 CAVAC Overview
11.10.3 CAVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 CAVAC Recent Developments
11.11 Rosenbusch
11.11.1 Rosenbusch Corporation Information
11.11.2 Rosenbusch Overview
11.11.3 Rosenbusch Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Rosenbusch Recent Developments
11.12 Agrovet
11.12.1 Agrovet Corporation Information
11.12.2 Agrovet Overview
11.12.3 Agrovet Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Agrovet Recent Developments
11.13 Vecol
11.13.1 Vecol Corporation Information
11.13.2 Vecol Overview
11.13.3 Vecol Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Vecol Recent Developments
11.14 CVCRI
11.14.1 CVCRI Corporation Information
11.14.2 CVCRI Overview
11.14.3 CVCRI Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 CVCRI Recent Developments
11.15 IVPM
11.15.1 IVPM Corporation Information
11.15.2 IVPM Overview
11.15.3 IVPM Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 IVPM Recent Developments
11.16 Prondil
11.16.1 Prondil Corporation Information
11.16.2 Prondil Overview
11.16.3 Prondil Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.16.4 Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Prondil Recent Developments
11.17 CDV
11.17.1 CDV Corporation Information
11.17.2 CDV Overview
11.17.3 CDV Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.17.4 CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 CDV Recent Developments
11.18 Indian Immunologicals
11.18.1 Indian Immunologicals Corporation Information
11.18.2 Indian Immunologicals Overview
11.18.3 Indian Immunologicals Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.18.4 Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Indian Immunologicals Recent Developments
11.19 Botswana Vaccine Institute
11.19.1 Botswana Vaccine Institute Corporation Information
11.19.2 Botswana Vaccine Institute Overview
11.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.19.4 Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Botswana Vaccine Institute Recent Developments
11.20 Ceva Santé Animale
11.20.1 Ceva Santé Animale Corporation Information
11.20.2 Ceva Santé Animale Overview
11.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.20.4 Ceva Santé Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Ceva Santé Animale Recent Developments
11.21 Intervac
11.21.1 Intervac Corporation Information
11.21.2 Intervac Overview
11.21.3 Intervac Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.21.4 Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 Intervac Recent Developments
11.22 JOVAC
11.22.1 JOVAC Corporation Information
11.22.2 JOVAC Overview
11.22.3 JOVAC Anthrax Vaccines Sales, Price, Revenue and Gross Margin (2017-2022)
11.22.4 JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
11.22.5 JOVAC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anthrax Vaccines Industry Chain Analysis
12.2 Anthrax Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anthrax Vaccines Production Mode & Process
12.4 Anthrax Vaccines Sales and Marketing
12.4.1 Anthrax Vaccines Sales Channels
12.4.2 Anthrax Vaccines Distributors
12.5 Anthrax Vaccines Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Anthrax Vaccines Industry Trends
13.2 Anthrax Vaccines Market Drivers
13.3 Anthrax Vaccines Market Challenges
13.4 Anthrax Vaccines Market Restraints
14 Key Findings in The Global Anthrax Vaccines Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Anthrax Vaccines Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Live Vaccines
    Table 3. Major Manufacturers of Cell free PA Vaccines
    Table 4. Global Anthrax Vaccines Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Anthrax Vaccines Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 7. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)
    Table 8. Global Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 9. Global Anthrax Vaccines Sales Market Share by Region (2023-2028)
    Table 10. Global Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Anthrax Vaccines Revenue Market Share by Region (2017-2022)
    Table 12. Global Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Anthrax Vaccines Revenue Market Share by Region (2023-2028)
    Table 14. Global Anthrax Vaccines Sales by Manufacturers (2017-2022) & (M Doses)
    Table 15. Global Anthrax Vaccines Sales Share by Manufacturers (2017-2022)
    Table 16. Global Anthrax Vaccines Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Anthrax Vaccines Revenue Share by Manufacturers (2017-2022)
    Table 18. Anthrax Vaccines Price by Manufacturers (2017-2022) &(USD/Dose)
    Table 19. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Anthrax Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2021)
    Table 21. Anthrax Vaccines Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Anthrax Vaccines Product Offered
    Table 23. Date of Manufacturers Enter into Anthrax Vaccines Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 26. Global Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 27. Global Anthrax Vaccines Sales Share by Type (2017-2022)
    Table 28. Global Anthrax Vaccines Sales Share by Type (2023-2028)
    Table 29. Global Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Anthrax Vaccines Revenue Share by Type (2017-2022)
    Table 32. Global Anthrax Vaccines Revenue Share by Type (2023-2028)
    Table 33. Anthrax Vaccines Price by Type (2017-2022) & (USD/Dose)
    Table 34. Global Anthrax Vaccines Price Forecast by Type (2023-2028) & (USD/Dose)
    Table 35. Global Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 36. Global Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 37. Global Anthrax Vaccines Sales Share by Application (2017-2022)
    Table 38. Global Anthrax Vaccines Sales Share by Application (2023-2028)
    Table 39. Global Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Anthrax Vaccines Revenue Share by Application (2017-2022)
    Table 42. Global Anthrax Vaccines Revenue Share by Application (2023-2028)
    Table 43. Anthrax Vaccines Price by Application (2017-2022) & (USD/Dose)
    Table 44. Global Anthrax Vaccines Price Forecast by Application (2023-2028) & (USD/Dose)
    Table 45. North America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 46. North America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 47. North America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 50. North America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 51. North America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 54. North America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 55. North America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 58. Europe Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 59. Europe Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 62. Europe Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 63. Europe Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 66. Europe Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 67. Europe Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 70. Asia Pacific Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 71. Asia Pacific Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 74. Asia Pacific Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 75. Asia Pacific Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Anthrax Vaccines Sales by Region (2017-2022) & (M Doses)
    Table 78. Asia Pacific Anthrax Vaccines Sales by Region (2023-2028) & (M Doses)
    Table 79. Asia Pacific Anthrax Vaccines Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Anthrax Vaccines Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 82. Latin America Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 83. Latin America Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 86. Latin America Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 87. Latin America Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 90. Latin America Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 91. Latin America Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Anthrax Vaccines Sales by Type (2017-2022) & (M Doses)
    Table 94. Middle East and Africa Anthrax Vaccines Sales by Type (2023-2028) & (M Doses)
    Table 95. Middle East and Africa Anthrax Vaccines Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Anthrax Vaccines Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Anthrax Vaccines Sales by Application (2017-2022) & (M Doses)
    Table 98. Middle East and Africa Anthrax Vaccines Sales by Application (2023-2028) & (M Doses)
    Table 99. Middle East and Africa Anthrax Vaccines Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Anthrax Vaccines Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Anthrax Vaccines Sales by Country (2017-2022) & (M Doses)
    Table 102. Middle East and Africa Anthrax Vaccines Sales by Country (2023-2028) & (M Doses)
    Table 103. Middle East and Africa Anthrax Vaccines Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Anthrax Vaccines Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Emergent BioSolutions Corporation Information
    Table 106. Emergent BioSolutions Description and Major Businesses
    Table 107. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 108. Emergent BioSolutions Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Emergent BioSolutions Recent Developments
    Table 110. Merial Corporation Information
    Table 111. Merial Description and Major Businesses
    Table 112. Merial Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 113. Merial Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Merial Recent Developments
    Table 115. Merck Corporation Information
    Table 116. Merck Description and Major Businesses
    Table 117. Merck Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 118. Merck Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Merck Recent Developments
    Table 120. Zoetis Corporation Information
    Table 121. Zoetis Description and Major Businesses
    Table 122. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 123. Zoetis Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Zoetis Recent Developments
    Table 125. Bayer Sanidad Animal Corporation Information
    Table 126. Bayer Sanidad Animal Description and Major Businesses
    Table 127. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 128. Bayer Sanidad Animal Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Bayer Sanidad Animal Recent Developments
    Table 130. Colorado Serum Corporation Information
    Table 131. Colorado Serum Description and Major Businesses
    Table 132. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 133. Colorado Serum Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. Colorado Serum Recent Developments
    Table 135. PharmAthene Corporation Information
    Table 136. PharmAthene Description and Major Businesses
    Table 137. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 138. PharmAthene Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. PharmAthene Recent Developments
    Table 140. Tiankang Corporation Information
    Table 141. Tiankang Description and Major Businesses
    Table 142. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 143. Tiankang Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Tiankang Recent Developments
    Table 145. Biogénesis-Bago Corporation Information
    Table 146. Biogénesis-Bago Description and Major Businesses
    Table 147. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 148. Biogénesis-Bago Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Biogénesis-Bago Recent Developments
    Table 150. CAVAC Corporation Information
    Table 151. CAVAC Description and Major Businesses
    Table 152. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 153. CAVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. CAVAC Recent Developments
    Table 155. Rosenbusch Corporation Information
    Table 156. Rosenbusch Description and Major Businesses
    Table 157. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 158. Rosenbusch Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Rosenbusch Recent Developments
    Table 160. Agrovet Corporation Information
    Table 161. Agrovet Description and Major Businesses
    Table 162. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 163. Agrovet Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Agrovet Recent Developments
    Table 165. Vecol Corporation Information
    Table 166. Vecol Description and Major Businesses
    Table 167. Vecol Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 168. Vecol Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 169. Vecol Recent Developments
    Table 170. CVCRI Corporation Information
    Table 171. CVCRI Description and Major Businesses
    Table 172. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 173. CVCRI Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 174. CVCRI Recent Developments
    Table 175. IVPM Corporation Information
    Table 176. IVPM Description and Major Businesses
    Table 177. IVPM Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 178. IVPM Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 179. IVPM Recent Developments
    Table 180. Prondil Corporation Information
    Table 181. Prondil Description and Major Businesses
    Table 182. Prondil Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 183. Prondil Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 184. Prondil Recent Developments
    Table 185. CDV Corporation Information
    Table 186. CDV Description and Major Businesses
    Table 187. CDV Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 188. CDV Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 189. CDV Recent Developments
    Table 190. Indian Immunologicals Corporation Information
    Table 191. Indian Immunologicals Description and Major Businesses
    Table 192. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 193. Indian Immunologicals Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 194. Indian Immunologicals Recent Developments
    Table 195. Botswana Vaccine Institute Corporation Information
    Table 196. Botswana Vaccine Institute Description and Major Businesses
    Table 197. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 198. Botswana Vaccine Institute Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 199. Botswana Vaccine Institute Recent Developments
    Table 200. Ceva Santé Animale Corporation Information
    Table 201. Ceva Santé Animale Description and Major Businesses
    Table 202. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 203. Ceva Santé Animale Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 204. Ceva Santé Animale Recent Developments
    Table 205. Intervac Corporation Information
    Table 206. Intervac Description and Major Businesses
    Table 207. Intervac Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 208. Intervac Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 209. Intervac Recent Developments
    Table 210. JOVAC Corporation Information
    Table 211. JOVAC Description and Major Businesses
    Table 212. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
    Table 213. JOVAC Anthrax Vaccines Product Model Numbers, Pictures, Descriptions and Specifications
    Table 214. JOVAC Recent Developments
    Table 215. Key Raw Materials Lists
    Table 216. Raw Materials Key Suppliers Lists
    Table 217. Anthrax Vaccines Distributors List
    Table 218. Anthrax Vaccines Customers List
    Table 219. Anthrax Vaccines Market Trends
    Table 220. Anthrax Vaccines Market Drivers
    Table 221. Anthrax Vaccines Market Challenges
    Table 222. Anthrax Vaccines Market Restraints
    Table 223. Research Programs/Design for This Report
    Table 224. Key Data Information from Secondary Sources
    Table 225. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anthrax Vaccines Product Picture
    Figure 3. Global Anthrax Vaccines Market Share by Type in 2021 & 2028
    Figure 3. Live Vaccines Product Picture
    Figure 4. Cell free PA Vaccines Product Picture
    Figure 5. Global Anthrax Vaccines Market Share by Application in 2021 & 2028
    Figure 6. Human Use
    Figure 7. Animal Use
    Figure 8. Anthrax Vaccines Report Years Considered
    Figure 9. Global Anthrax Vaccines Sales 2017-2028 (M Doses)
    Figure 10. Global Anthrax Vaccines Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Anthrax Vaccines Revenue 2017-2028 (US$ Million)
    Figure 12. Global Anthrax Vaccines Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Anthrax Vaccines Sales Market Share by Region (2017-2022)
    Figure 14. Global Anthrax Vaccines Sales Market Share by Region (2023-2028)
    Figure 15. North America Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 16. North America Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 18. Europe Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 20. Asia-Pacific Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 22. Latin America Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Anthrax Vaccines Sales YoY (2017-2028) & (M Doses)
    Figure 24. Middle East & Africa Anthrax Vaccines Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Anthrax Vaccines Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Anthrax Vaccines in the World: Market Share by Anthrax Vaccines Revenue in 2021
    Figure 27. Global Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Anthrax Vaccines Sales Market Share by Type (2017-2028)
    Figure 29. Global Anthrax Vaccines Revenue Market Share by Type (2017-2028)
    Figure 30. Global Anthrax Vaccines Sales Market Share by Application (2017-2028)
    Figure 31. Global Anthrax Vaccines Revenue Market Share by Application (2017-2028)
    Figure 32. North America Anthrax Vaccines Sales Market Share by Type (2017-2028)
    Figure 33. North America Anthrax Vaccines Revenue Market Share by Type (2017-2028)
    Figure 34. North America Anthrax Vaccines Sales Market Share by Application (2017-2028)
    Figure 35. North America Anthrax Vaccines Revenue Market Share by Application (2017-2028)
    Figure 36. North America Anthrax Vaccines Sales Share by Country (2017-2028)
    Figure 37. North America Anthrax Vaccines Revenue Share by Country (2017-2028)
    Figure 38. U.S. Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Anthrax Vaccines Sales Market Share by Type (2017-2028)
    Figure 41. Europe Anthrax Vaccines Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Anthrax Vaccines Sales Market Share by Application (2017-2028)
    Figure 43. Europe Anthrax Vaccines Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Anthrax Vaccines Sales Share by Country (2017-2028)
    Figure 45. Europe Anthrax Vaccines Revenue Share by Country (2017-2028)
    Figure 46. Germany Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 47. France Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Anthrax Vaccines Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Anthrax Vaccines Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Anthrax Vaccines Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Anthrax Vaccines Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Anthrax Vaccines Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Anthrax Vaccines Revenue Share by Region (2017-2028)
    Figure 57. China Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 60. India Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 62. China Taiwan Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 66. Latin America Anthrax Vaccines Sales Market Share by Type (2017-2028)
    Figure 67. Latin America Anthrax Vaccines Revenue Market Share by Type (2017-2028)
    Figure 68. Latin America Anthrax Vaccines Sales Market Share by Application (2017-2028)
    Figure 69. Latin America Anthrax Vaccines Revenue Market Share by Application (2017-2028)
    Figure 70. Latin America Anthrax Vaccines Sales Share by Country (2017-2028)
    Figure 71. Latin America Anthrax Vaccines Revenue Share by Country (2017-2028)
    Figure 72. Mexico Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 73. Brazil Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 74. Argentina Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 75. Middle East and Africa Anthrax Vaccines Sales Market Share by Type (2017-2028)
    Figure 76. Middle East and Africa Anthrax Vaccines Revenue Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Anthrax Vaccines Sales Market Share by Application (2017-2028)
    Figure 78. Middle East and Africa Anthrax Vaccines Revenue Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Anthrax Vaccines Sales Share by Country (2017-2028)
    Figure 80. Middle East and Africa Anthrax Vaccines Revenue Share by Country (2017-2028)
    Figure 81. Turkey Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 82. Saudi Arabia Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 83. UAE Anthrax Vaccines Revenue (2017-2028) & (US$ Million)
    Figure 84. Anthrax Vaccines Value Chain
    Figure 85. Anthrax Vaccines Production Process
    Figure 86. Channels of Distribution
    Figure 87. Distributors Profiles
    Figure 88. Bottom-up and Top-down Approaches for This Report
    Figure 89. Data Triangulation
    Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user(purchaser of the report) to access the PDF.

Electronic (PDF)
$7350
This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Accenture
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Fish Oil Market Size Manufacturers Supply Chain Sales Channel and Clients 2022 2028
Global and United States Fish Oil Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-39G12037
Mon Nov 07 00:00:00 UTC 2022

Add to Cart

Global Bromfenac Sodium Eye Drops Market Research Report 2022
Global Bromfenac Sodium Eye Drops Market Insights, Forecast to 2028

120 Pages
Type: Report
Code: QYRE-Auto-12B11033
Thu Nov 03 00:00:00 UTC 2022

Add to Cart

Global Prescription Delivery Service Market Insights and Forecast to 2028
Global Prescription Delivery Service Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-1H6093
Mon Oct 24 00:00:00 UTC 2022

Add to Cart

Global Iodine Contrast Media Market Insights Forecast to 2028
Global Iodine Contrast Media Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-4Q10408
Mon Oct 24 00:00:00 UTC 2022

Add to Cart